Gossamer Bio Inc. (GOSS) Misses Q2 EPS by 29c

Gossamer Bio Inc. (NASDAQ: GOSS) reported Q2 EPS of $0.22, $0.29 worse than the analyst estimate of $0.51. Revenue for the quarter came in at $95.84 million versus the consensus estimate of $114.29 million.

For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Rocket Lab launches U.S. Space Force mission in record 16 hours
• A. O. Smith CEO Stephen Shafer named chairman